SODIUM

4 of 4 resultsNews

  • Newham increases POCT capabilities

    Newham increases POCT capabilities

    NEWHAM University Hospital has placed a clinical chemistry analyser in its ‘hot lab’ increasing its point-of-care testing (POCT) facilities.

    20/01/2009

  • NPS urge re-think brand substitution

    NPS urge re-think brand substitution

    THE NATIONAL Prescribing Service has urged Australian doctors and pharmacists to use extreme care when considering brand-substitution for anti-epileptic drugs even when listed as bioequivalent on the Pharmaceutical Benefits Scheme.

    14/02/2009

  • Alchemia and Dr Reddy’s Laboratories to commercialise generic fondaparinux

    Alchemia and Dr Reddy’s Laboratories to commercialise generic fondaparinux

    ALCHEMIA says its global manufacturing and US marketing partner Dr Reddy’s Laboratories has submitted an Abbreviated New Drug Application (ANDA) with the US FDA for Fondaparinux Sodium for Injection in 2.5mg, 5.0mg, 7.5mg and 10.0mg doses.

    17/03/2009

  • Once-a-month osteoporosis therapy now available on PBS

    Once-a-month osteoporosis therapy now available on PBS

    MORE than 2 million Australians living with osteoporosis1 are set to benefit from the first once-a-month osteoporosis therapy to be listed on the Pharmaceutical Benefits Scheme (PBS) today (July 1, 2009).

    01/07/2009

 

1 of 1 resultsProducts

     

    Find more information about sodium on our other sites.

    to get Clinical Lab
    delivered to your inbox

    Latest from Twitter

      Getting your tweets...